The WACC of Raily Aesthetic Medicine International Holdings Ltd (2135.HK) is 7.0%.
| Range | Selected | |
| Cost of equity | 7.70% - 10.20% | 8.95% |
| Tax rate | 8.20% - 13.20% | 10.70% |
| Cost of debt | 4.00% - 7.00% | 5.50% |
| WACC | 5.7% - 8.2% | 7.0% |
| Category | Low | High |
| Long-term bond rate | 2.9% | 3.4% |
| Equity market risk premium | 6.0% | 7.0% |
| Adjusted beta | 0.8 | 0.91 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.70% | 10.20% |
| Tax rate | 8.20% | 13.20% |
| Debt/Equity ratio | 0.93 | 0.93 |
| Cost of debt | 4.00% | 7.00% |
| After-tax WACC | 5.7% | 8.2% |
| Selected WACC | 7.0% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 2135.HK:
cost_of_equity (8.95%) = risk_free_rate (3.15%) + equity_risk_premium (6.50%) * adjusted_beta (0.8) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.